findmyKOL

Raed Abdelhadi, MD

Basic profile

Minneapolis Heart Institute Foundation

ORCIDNone on fileNPI
RegionMinneapolis, MN · MidwestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Raed Abdelhadi is a Cardiology physician affiliated with Minneapolis Heart Institute Foundation. OpenAlex indexes 59 publications with 803 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
59publications

Distinct works indexed by OpenAlex.

803citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

800 E 28th St
Suite H2100
Minneapolis, MN 554073723

Telephone

612-775-3030

Provider last certified this registry record 6 Nov 2020.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    57.5%
    Beta blocker39.4%
    Sotalol45%Metoprolol Succinate35%Metoprolol Tartrate20%
    Part D52 patients
    Antiarrhythmic11.9%
    Flecainide Acetate52%Amiodarone Hcl20%Multaq16%Propafenone Hcl13%
    Part D<11 patients

    + 1 more class in this area

  • Blood & clotting

    42.5%
    Factor Xa inhibitor42.5%
    Eliquis77%Xarelto23%
    Part D64 patients
Where care is delivered (Part B)3.1% facility · 96.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”